ddr-1 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of DDR1 Antibody

DDR1 antibodies are designed to inhibit or modulate DDR1, a transmembrane receptor that binds collagen and regulates extracellular matrix (ECM) remodeling. DDR1 is overexpressed in epithelial cancers (e.g., breast, lung, pancreatic) and fibrotic diseases, where it promotes tumor invasion, metastasis, and immune evasion .

Key Features of DDR1 Antibodies

  • Target: Extracellular domain (ECD) or kinase domain of DDR1 .

  • Applications: Research (e.g., immunohistochemistry, Western blot), therapeutic development .

  • Relevance: High DDR1 expression correlates with poor prognosis in cancers and resistance to immunotherapy .

Mechanism of Action

DDR1 antibodies disrupt collagen-DDR1 interactions or downstream signaling:

Functional Mechanisms

MechanismEffectExample Antibody
Block collagen bindingPrevents DDR1 activation and ECM remodelingPRTH-101
Inhibit kinase activityReduces phosphorylation and downstream signaling (e.g., EZH2, NF-κB) BSB-173
Disrupt collagen alignmentBreaks physical tumor barriers, enhancing T-cell infiltration PRTH-101
Prevent DDR1 sheddingStabilizes DDR1 on cell surface, reducing soluble ECD-mediated effects PRTH-101

Preclinical Insights

  • Immune Exclusion: DDR1 promotes collagen fiber alignment, forming a physical barrier that excludes CD8+ T cells from tumors. Antibodies like PRTH-101 disrupt this barrier, restoring antitumor immunity .

  • Metastasis: DDR1 activation in pancreatic cancer induces CXCL5 secretion, recruiting neutrophils and driving metastasis via NETosis .

  • Therapeutic Synergy: Combining DDR1 antibodies (e.g., PRTH-101) with PD-1 inhibitors enhances tumor regression in microsatellite-stable colorectal cancer models .

Clinical Development

AntibodyStageIndicationKey Findings
PRTH-101Phase 1c Advanced solid tumorsSafe and tolerable; disrupts collagen barriers, enhances T-cell infiltration .
BSB-173Research useFFPE tissue stainingValidated for cytoplasmic DDR1 detection in cancer tissues .
AF2396Research useWestern blot/ELISADetects DDR1 at ~100–140 kDa; cross-reacts weakly with DDR2 .

Therapeutic Potential

  • Immune Modulation: DDR1 antibodies reverse immune exclusion, sensitizing tumors to checkpoint inhibitors .

  • Biomarker-Driven Use: High DDR1/collagen I expression predicts response in colorectal, breast, and lung cancers .

  • Safety: PRTH-101 shows no significant toxicity in Phase 1 trials, supporting further development .

Challenges and Future Directions

  • Target Specificity: DDR1 and DDR2 share structural homology, necessitating selective antibodies .

  • Resistance Mechanisms: Tumor heterogeneity and compensatory pathways (e.g., alternative collagen receptors) may limit efficacy.

  • Combination Strategies: Ongoing trials explore DDR1 antibodies with chemotherapy, radiation, or immunotherapy .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ddr-1 antibody; C25F6.4Discoidin domain-containing receptor A antibody
Target Names
ddr-1
Uniprot No.

Target Background

Function
DDR-1 is a receptor that, in conjunction with SVH-4, participates in axon guidance during nervous system development, establishing the tracts for the ventral and dorsal nerve cords. It may play a role in promoting axon regeneration following injury in D-type motor neurons.
Database Links

KEGG: cel:CELE_C25F6.4

STRING: 6239.C25F6.4

UniGene: Cel.11305

Protein Families
Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily
Subcellular Location
Cell membrane; Single-pass type I membrane protein. Cell projection, axon. Perikaryon.
Tissue Specificity
Expressed in neurons in head and tail, some motoneurons in ventral nerve cord, in PVP interneurons, pharynx and stomato-intestinal muscle.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.